RenovoRx (RNXT) Stock Chart & Stock Price History $1.29 -0.01 (-0.77%) Closing price 07/21/2025 04:00 PM EasternExtended Trading$1.29 +0.00 (+0.31%) As of 07/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RenovoRx Stock Price Performance The RenovoRx (RNXT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 9.32%, with a year-to-date return of 0.00%. In the past month, the stock has decreased 6.52%, reflecting recent market activity. As of the latest close, RenovoRx traded at $1.29 with a market cap of $47.18 million and volume of 119,957 shares. Receive RNXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.77%1 Month Performance-6.52%3 Month Performance+35.79%Year-To-Date Performance0.00%1 Year Performance+9.32% RNXT Stock Chart for Tuesday, July, 22, 2025 RNXT Chart by TradingView RenovoRx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/21/2025$1.30$1.29-0.77%$1.31$1.26119,957 shs$47.18 million07/18/2025$1.30$1.30$1.35$1.28128,984 shs$47.54 million07/17/2025$1.30$1.30$1.32$1.28125,806 shs$47.54 million07/16/2025$1.32$1.30-1.52%$1.33$1.27100,785 shs$47.54 million07/15/2025$1.40$1.32-5.71%$1.39$1.30242,438 shs$48.28 million07/14/2025$1.29$1.40+8.95%$1.40$1.29214,312 shs$51.20 million07/11/2025$1.34$1.29-4.10%$1.37$1.28150,962 shs$47.00 million07/10/2025$1.32$1.34+1.90%$1.37$1.3039,608 shs$49.00 million07/09/2025$1.30$1.32+1.15%$1.35$1.2982,945 shs$48.09 million07/08/2025$1.32$1.30-1.52%$1.34$1.30149,940 shs$47.54 million Get the Latest News and Ratings for RNXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. 07/07/2025$1.35$1.32-2.22%$1.38$1.3277,655 shs$48.27 million07/04/2025$1.35$1.35$1.37$1.2993,331 shs$49.37 million07/03/2025$1.30$1.35+3.85%$1.37$1.2993,331 shs$49.37 million07/02/2025$1.27$1.30+2.36%$1.31$1.2794,977 shs$47.54 million07/01/2025$1.32$1.27-3.42%$1.33$1.2754,611 shs$46.44 million06/30/2025$1.28$1.32+2.73%$1.34$1.27143,649 shs$48.09 million06/27/2025$1.35$1.28-5.19%$1.36$1.28243,724 shs$46.81 million06/26/2025$1.38$1.35-2.17%$1.39$1.32141,776 shs$49.37 million06/25/2025$1.42$1.38-2.82%$1.40$1.32218,771 shs$50.47 million06/24/2025$1.41$1.42+0.71%$1.42$1.37334,141 shs$51.93 million06/23/2025$1.38$1.41+2.17%$1.41$1.33233,772 shs$51.56 million Related Companies ALMS Stock Price Chart SXTC Stock Price Chart CTMX Stock Price Chart FDMT Stock Price Chart GNFT Stock Price Chart GALT Stock Price Chart DMAC Stock Price Chart PBYI Stock Price Chart VYGR Stock Price Chart ENGN Stock Price Chart Receive RNXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNXT) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
